Cardiac Adverse Events With Remdesivir in COVID-19 Infection

被引：73

作者：

Gupta, Anupam K. ^{[1
]}

Parker, Barbara M. ^{[2
]}

Priyadarshi, Vikash ^{[3
]}

Parker, John ^{[4
]}

机构：

[1] Univ Miami Hosp, Surg, Miami, FL 33136 USA

[2] AdventHlth Orlando, Clin Pharm, Orlando, FL USA

[3] Rockledge Reg Med Ctr, Med, Rockledge, FL USA

[4] Adventhlth Altamonte, Obstet & Gynaecol, Altamonte Springs, FL USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2020年 / 12卷 / 10期

关键词：

remdesivir; qtc prolongation; bradycardia;

D O I：

10.7759/cureus.11132

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Since December 2019, coronavirus has gradually progressed to a pandemic with no efficacious treatment. Remdesivir is an antiviral medication and inhibitor of viral RNA dependent RNA polymerase with inhibitory action against SARS-CoV virus. Two patients diagnosed with coronavirus infection with worsening respiratory status were initiated with multimodality therapy with antibiotics, steroids and remdesivir. After initiation of remdesivir, the patients' developed bradycardia, with one of the two also showing signs of worsening QT interval. This reverted upon stopping remdesvir therapy. The prevalence of bradycardia with prolonged QT interval is not well-known yet with this medication.

引用

页数：5

共 15 条

[1] Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019 [J].

Aggarwal, Gaurav ;

Henry, Brandon Michael ;

Aggarwal, Saurabh ;

Bangalore, Sripal .

AMERICAN JOURNAL OF CARDIOLOGY, 2020, 128 :147-150

[2] Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease [J].

Agostini, Maria L. ;

Andres, Erica L. ;

Sims, Amy C. ;

Graham, Rachel L. ;

Sheahan, Timothy P. ;

Lu, Xiaotao ;

Smith, Everett Clinton ;

Case, James Brett ;

Feng, Joy Y. ;

Jordan, Robert ;

Ray, Adrian S. ;

Cihlar, Tomas ;

Siegel, Dustin ;

Mackman, Richard L. ;

Clarke, Michael O. ;

Baric, Ralph S. ;

Denison, Mark R. .

MBIO, 2018, 9 (02)

[3] Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019 [J].

Barlow, Ashley ;

Landolf, Kaitlin M. ;

Barlow, Brooke ;

Yeung, Siu Yan Amy ;

Heavner, Jason J. ;

Claassen, Cassidy W. ;

Heavner, Mojdeh S. .

PHARMACOTHERAPY, 2020, 40 (05) :416-437

[4]

Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]

[5] Compassionate Use of Remdesivir for Patients with Severe Covid-19 [J].

Grein, J. ;

Ohmagari, N. ;

Shin, D. ;

Diaz, G. ;

Asperges, E. ;

Castagna, A. ;

Feldt, T. ;

Green, G. ;

Green, M. L. ;

Lescure, F-X ;

Nicastri, E. ;

Oda, R. ;

Yo, K. ;

Quiros-Roldan, E. ;

Studemeister, A. ;

Redinski, J. ;

Ahmed, S. ;

Bernett, J. ;

Chelliah, D. ;

Chen, D. ;

Chihara, S. ;

Cohen, S. H. ;

Cunningham, J. ;

Monforte, A. DArminio ;

Ismail, S. ;

Kato, H. ;

Lapadula, G. ;

L'Her, E. ;

Maeno, T. ;

Majumder, S. ;

Massari, M. ;

Mora-Rillo, M. ;

Mutoh, Y. ;

Nguyen, D. ;

Verweij, E. ;

Zoufaly, A. ;

Osinusi, A. O. ;

DeZure, A. ;

Zhao, Y. ;

Zhong, L. ;

Chokkalingam, A. ;

Elboudwarej, E. ;

Telep, L. ;

Timbs, L. ;

Henne, I ;

Sellers, S. ;

Cao, H. ;

Tan, S. K. ;

Winterbourne, L. ;

Desai, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (24) :2327-2336

[6] Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects [J].

Humeniuk, Rita ;

Mathias, Anita ;

Cao, Huyen ;

Osinusi, Anu ;

Shen, Gong ;

Chng, Estelle ;

Ling, John ;

Vu, Amanda ;

German, Polina .

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05) :896-906

[7] An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment [J].

Javorac, Dragana ;

Grahovac, Lazar ;

Manic, Luka ;

Stojilkovic, Nikola ;

Andelkovic, Milena ;

Bulat, Zorica ;

Dukic-Cosic, Danijela ;

Curcic, Marijana ;

Djordjevic, Aleksandra Buha .

FOOD AND CHEMICAL TOXICOLOGY, 2020, 144

[8] Rapid review for the anti-coronavirus effect of remdesivir [J].

Li, Ziyi ;

Wang, Xiaojie ;

Cao, Donglin ;

Sun, Ruilin ;

Li, Cheng ;

Li, Guowei .

DRUG DISCOVERIES AND THERAPEUTICS, 2020, 14 (02) :73-76

[9] A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir [J].

Liang, Chengyuan ;

Tian, Lei ;

Liu, Yuzhi ;

Hui, Nan ;

Qiao, Guaiping ;

Li, Han ;

Shi, Zhenfeng ;

Tang, Yonghong ;

Zhang, Dezhu ;

Xie, Xiaolin ;

Zhao, Xu .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 201

[10] A Review of Remdesivir for COVID-19: Data to Date [J].

Mehta, Monica ;

Shyh, Grace I. .

CARDIOLOGY IN REVIEW, 2020, 28 (06) :332-334

← 1 2 →